Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sumner H Burstein

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Bioorganic & Medicinal Chemistry|May 21, 2019
Eicosanoid mediation of cannabinoid actionsSumner H Burstein
Bioorganic & Medicinal Chemistry|April 16, 2014
The cannabinoid acids, analogs and endogenous counterpartsSumner H Burstein
Molecular Pharmacology|November 16, 2017
<i>N-</i>Acyl Amino Acids (Elmiric Acids): Endogenous Signaling Molecules with Therapeutic PotentialSumner H Burstein
Pharmacology Research & Perspectives|April 12, 2018
Ajulemic acid: potential treatment for chronic inflammationSumner H Burstein
Prostaglandins & Other Lipid Mediators|January 14, 2020
The chemistry, biology and pharmacology of the cyclopentenone prostaglandinsSumner H Burstein
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 21, 2016
Cannabinoids, inflammation, and fibrosisRobert B Zurier, Sumner H Burstein
Pharmacology Research & Perspectives|December 16, 2014
In vitro metabolism and metabolic effects of ajulemic acid, a synthetic cannabinoid agonistSumner H Burstein, Mark A Tepper
The AAPS Journal|February 10, 2009
Cannabinoids, endocannabinoids, and related analogs in inflammationSumner H Burstein, Robert B Zurier
Bioorganic & Medicinal Chemistry|May 27, 2014
Ultrapure ajulemic acid has improved CB2 selectivity with reduced CB1 activityMark A Tepper, Robert B Zurier, Sumner H Burstein
Life Sciences|July 9, 2004
Ajulemic acid: A novel cannabinoid produces analgesia without a "high"Sumner H Burstein, Matthias Karst, Udo Schneider, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Bioorganic & Medicinal Chemistry|May 21, 2019
Eicosanoid mediation of cannabinoid actionsSumner H Burstein
Bioorganic & Medicinal Chemistry|April 16, 2014
The cannabinoid acids, analogs and endogenous counterpartsSumner H Burstein
Molecular Pharmacology|November 16, 2017
<i>N-</i>Acyl Amino Acids (Elmiric Acids): Endogenous Signaling Molecules with Therapeutic PotentialSumner H Burstein
Pharmacology Research & Perspectives|April 12, 2018
Ajulemic acid: potential treatment for chronic inflammationSumner H Burstein
Prostaglandins & Other Lipid Mediators|January 14, 2020
The chemistry, biology and pharmacology of the cyclopentenone prostaglandinsSumner H Burstein
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 21, 2016
Cannabinoids, inflammation, and fibrosisRobert B Zurier, Sumner H Burstein
Pharmacology Research & Perspectives|December 16, 2014
In vitro metabolism and metabolic effects of ajulemic acid, a synthetic cannabinoid agonistSumner H Burstein, Mark A Tepper
The AAPS Journal|February 10, 2009
Cannabinoids, endocannabinoids, and related analogs in inflammationSumner H Burstein, Robert B Zurier
Bioorganic & Medicinal Chemistry|May 27, 2014
Ultrapure ajulemic acid has improved CB2 selectivity with reduced CB1 activityMark A Tepper, Robert B Zurier, Sumner H Burstein
Life Sciences|July 9, 2004
Ajulemic acid: A novel cannabinoid produces analgesia without a "high"Sumner H Burstein, Matthias Karst, Udo Schneider, et al.
Pageof 2